Welcome to Friday’s Overnight Health Care.
FDA authorization of Pfizer’s COVID-19 vaccine candidate is expected soon, but the White House is pushing the agency to move even quicker. Meanwhile, the Trump administration is buying another 100 million doses of a similar candidate from Moderna. And a surprise billing fix might happen after all.
Let’s start with the COVID vaccine:
White House presses FDA chief over COVID-19 vaccine
Top Trump administration officials are turning up the heat on the Food and Drug Administration (FDA) to quickly authorize emergency use of the country’s first coronavirus vaccine.
White House chief of staff Mark Meadows phoned FDA Commissioner Stephen Hahn on Friday and pushed him to clear